DrugPatentWatch Database Preview
Email this page to a colleague» See Plans and Pricing
« Back to Dashboard
D-Tryptophan is an investigational drug.
There have been 13 clinical trials for D-Tryptophan. The most recent clinical trial was a Phase 1 trial, which was initiated on August 1st 2003.
The most common disease conditions in clinical trials are Breast Neoplasms, Adenocarcinoma, and Glioma. The leading clinical trial sponsors are National Cancer Institute (NCI), NewLink Genetics Corporation, and H. Lee Moffitt Cancer Center and Research Institute.
Recent Clinical Trials for D-Tryptophan
|Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer||National Cancer Institute (NCI)||Phase 3|
|Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer||Southwest Oncology Group||Phase 3|
|Enzalutamide Versus Standard Androgen Deprivation Therapy for the Treatment Hormone Sensitive Prostate Cancer||University of Colorado, Denver||Phase 2|